Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 10 | 2020 | 355 | 1.710 |
Why?
|
| Brain Neoplasms | 8 | 2020 | 637 | 1.020 |
Why?
|
| Cranial Irradiation | 5 | 2020 | 94 | 0.740 |
Why?
|
| Salvage Therapy | 5 | 2020 | 135 | 0.730 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 17 | 0.640 |
Why?
|
| Histiocytic Sarcoma | 1 | 2018 | 2 | 0.570 |
Why?
|
| Lymphoma, Follicular | 1 | 2018 | 17 | 0.560 |
Why?
|
| Computer Simulation | 1 | 2019 | 251 | 0.540 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 442 | 0.520 |
Why?
|
| Prognosis | 8 | 2020 | 1529 | 0.490 |
Why?
|
| Postoperative Complications | 1 | 2020 | 818 | 0.450 |
Why?
|
| Osteosarcoma | 1 | 2012 | 10 | 0.370 |
Why?
|
| Ossification, Heterotopic | 1 | 2012 | 21 | 0.360 |
Why?
|
| Radiation Injuries | 1 | 2012 | 85 | 0.350 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 104 | 0.340 |
Why?
|
| Retrospective Studies | 9 | 2020 | 3609 | 0.300 |
Why?
|
| Aged | 11 | 2020 | 10249 | 0.290 |
Why?
|
| Male | 13 | 2020 | 19429 | 0.280 |
Why?
|
| Survival Rate | 4 | 2020 | 892 | 0.230 |
Why?
|
| Humans | 14 | 2020 | 32262 | 0.220 |
Why?
|
| Middle Aged | 10 | 2020 | 11837 | 0.220 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 2238 | 0.210 |
Why?
|
| Neoplasms | 3 | 2020 | 757 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 422 | 0.190 |
Why?
|
| Female | 10 | 2020 | 19935 | 0.170 |
Why?
|
| Treatment Outcome | 5 | 2019 | 3408 | 0.150 |
Why?
|
| Melanoma | 2 | 2019 | 166 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 106 | 0.140 |
Why?
|
| Astrocytoma | 1 | 2018 | 28 | 0.140 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2018 | 45 | 0.140 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 39 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2018 | 92 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 93 | 0.130 |
Why?
|
| Organ Size | 1 | 2018 | 221 | 0.130 |
Why?
|
| Nervous System Neoplasms | 1 | 2017 | 8 | 0.130 |
Why?
|
| Glioma | 1 | 2018 | 137 | 0.130 |
Why?
|
| Medicare | 1 | 2018 | 218 | 0.130 |
Why?
|
| Brain Death | 1 | 2017 | 23 | 0.130 |
Why?
|
| Bone Density | 1 | 2018 | 169 | 0.130 |
Why?
|
| Confidence Intervals | 1 | 2017 | 141 | 0.120 |
Why?
|
| Macaca mulatta | 1 | 2018 | 340 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2017 | 471 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 113 | 0.110 |
Why?
|
| Perciformes | 1 | 2015 | 1 | 0.110 |
Why?
|
| Ecosystem | 1 | 2015 | 7 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 200 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 298 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 904 | 0.100 |
Why?
|
| Smoking | 1 | 2017 | 505 | 0.100 |
Why?
|
| Models, Biological | 1 | 2015 | 408 | 0.090 |
Why?
|
| Risk Factors | 2 | 2019 | 3933 | 0.090 |
Why?
|
| Cisplatin | 1 | 2012 | 77 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2012 | 75 | 0.090 |
Why?
|
| Time Factors | 1 | 2017 | 2203 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 458 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 763 | 0.080 |
Why?
|
| Adult | 4 | 2018 | 9252 | 0.080 |
Why?
|
| Animals | 2 | 2018 | 8196 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2019 | 476 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 3893 | 0.060 |
Why?
|
| Disease Management | 1 | 2019 | 129 | 0.030 |
Why?
|
| Hearing Tests | 1 | 2017 | 12 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 312 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 772 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 591 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 373 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 322 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 367 | 0.030 |
Why?
|
| Polychaeta | 1 | 2015 | 1 | 0.030 |
Why?
|
| Geologic Sediments | 1 | 2015 | 2 | 0.030 |
Why?
|
| Water Pollutants, Chemical | 1 | 2015 | 4 | 0.030 |
Why?
|
| Population Density | 1 | 2015 | 9 | 0.030 |
Why?
|
| Particle Size | 1 | 2015 | 48 | 0.030 |
Why?
|
| California | 1 | 2015 | 61 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 2315 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 968 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2643 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 1211 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3509 | 0.020 |
Why?
|
| United States | 1 | 2018 | 4068 | 0.020 |
Why?
|